Amiko | Respiro offers sensors and AI to upgrade respiratory care
Amiko's Respiro offers advanced inhaler sensor technology and digital tools powered by AI to optimize treatment effectiveness and reduce the cost of COPD and asthma care.
Amiko, respiro,ai,respiratory,copd,asthma,care,health,treatment
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-15847,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-13.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.5,vc_responsive



The company’s first commercial product is Respiro®,

a digital platform that uses proprietary sensor technologies

to collect true adherence data from respiratory medication use and offers analytics

to assist professionals and empower patients to achieve better outcomes